Clinical Trials for Colorectal Cancer

GI004

Combination Chemotherapy, Bevacizumab, and/or Atezolizumab in Treating Patients With Deficient DNA Mismatch Repair Metastatic Colorectal Cancer, the COMMIT Study. View Details.

GI008

Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease. View details.


Learn more about Colorectal Cancer >

Our Affiliations

The Cancer FoundationNCIACHC Accredited

We’re Here to Help! Click Below to Get Started

Contact Us Now